Laura Matricardi
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management.
Journal: Cancer medicine
Published: February 23, 2024
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
Journal: Journal of the National Cancer Institute
Published: February 16, 2021
Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predisposition.
Journal: Scientific reports
Published: April 28, 2020
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Journal: Genetic epidemiology
Published: October 11, 2019
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.
Journal: Nature genetics
Published: September 23, 2019
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.
Journal: Cancer research
Published: July 01, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Journal: Human mutation
Published: January 30, 2019
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Journal: Breast cancer research : BCR
Published: September 28, 2015
Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127.
Journal: Biochimica et biophysica acta
Published: December 18, 2014
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
Journal: Human molecular genetics
Published: December 01, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: October 23, 2014
Genetic instability of the tumor suppressor gene FHIT in normal human cells.
Journal: Genes, chromosomes & cancer
Published: April 23, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026